Dr. Reddy's Laboratories (RDY)
Q1 2013 Earnings Call
July 19, 2012 9:00 am ET
Kedar Upadhye - Former Director
Umang Vohra - Chief Financial Officer, Executive Vice President and Member of Management Council
Kallam Satish Reddy - Managing Director, Chief Operating Officer, Executive Director, Member of the Management Council, Chairman of Management Committee, Member of Shareholders Grievance Committee, Member of Investment Committee and Member of Strategy Committee
Balaji V. Prasad - Barclays Capital, Research Division
Nimish Mehta - MP Advisors
Arvind Bothra - BofA Merrill Lynch, Research Division
Ravi K. Agrawal - Standard Chartered plc, Research Division
Manoj Garg - Edelweiss Capital Ltd., Research Division
Sameer Baisiwala - Morgan Stanley, Research Division
Anubhav Aggarwal - Crédit Suisse AG, Research Division
Bino Pathiparampil - IIFL Research
Bhavin Shah - Dolat Investments Ltd., Research Division
Ranjit Kapadia - Centrum Broking Private Limited, Research Division
Nitin Agarwal - IDFC Securities Ltd., Research Division
Abhay Shanbhag - Deutsche Bank AG, Research Division
Saion Mukherjee - Nomura Securities Co. Ltd., Research Division
Chirag Talati - Espirito Santo Investment Bank, Research Division
Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q1 FY '13 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to hand over the conference to Mr. Kedar Upadhye. Thank you, and over to you, sir.
Good morning, and good evening to all, and thank you for joining us today for Dr. Reddy's Earnings Call for quarter 1 of fiscal '13.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts